Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC
Clinical trial NCT04066491 · TERMINATED
Trial details
- NCT number
- NCT04066491
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-20
- Primary completion
- 2021-05-20
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.